Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes - Takeaways - MDSpire

Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes

  • By

  • Si-Tao Chen

  • Duan-Rui Zhou

  • Yun-Jun Ge

  • Lei Chang

  • Shu-Hui Guo

  • Guo-Sheng Wu

  • Ning-Han Feng

  • May 14, 2026

  • 0 min

Share

  • 1

    FADS3 is upregulated in clear cell renal cell carcinoma (ccRCC) and is associated with enhanced lipid metabolism in tumor tissues.

  • 2

    High expression of FADS3 remodels the tumor immune microenvironment and predicts poor prognosis for ccRCC patients.

  • 3

    Functional assays indicate that knockdown of FADS3 significantly reduces ccRCC cell proliferation, migration, and invasion.

  • 4

    FADS3 may promote ccRCC progression through activation of oncogenic signaling pathways, particularly the PI3K/Akt pathway.

  • 5

    Targeting FADS3 presents a potential therapeutic strategy for improving treatment outcomes in ccRCC.

Original Source(s)

Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes

  • by Si-Tao Chen, Duan-Rui Zhou, Yun-Jun Ge, Lei Chang, Shu-Hui Guo, Guo-Sheng Wu, Ning-Han Feng

  • May 14, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?